290 related articles for article (PubMed ID: 30097824)
21. Trametinib (GSK1120212) in the treatment of melanoma.
Salama AK; Kim KB
Expert Opin Pharmacother; 2013 Apr; 14(5):619-27. PubMed ID: 23432625
[TBL] [Abstract][Full Text] [Related]
22. Impact of trametinib on the neuropsychological profile of NF1 patients.
Lalancette E; Cantin É; Routhier MÈ; Mailloux C; Bertrand MC; Kiaei DS; Larouche V; Tabori U; Hawkins C; Ellezam B; Décarie JC; Théoret Y; Métras MÉ; McKeown T; Ospina LH; Vairy S; Ramaswamy V; Coltin H; Sultan S; Legault G; Bouffet É; Lafay-Cousin L; Hukin J; Erker C; Caru M; Dehaes M; Jabado N; Perreault S; Lippé S
J Neurooncol; 2024 May; 167(3):447-454. PubMed ID: 38443693
[TBL] [Abstract][Full Text] [Related]
23. Targeted therapy for infants with diencephalic syndrome: A case report and review of management strategies.
Wagner LM; Myseros JS; Lukins DE; Willen CM; Packer RJ
Pediatr Blood Cancer; 2018 May; 65(5):e26917. PubMed ID: 29369501
[TBL] [Abstract][Full Text] [Related]
24. Trametinib in metastatic melanoma.
Chopra N; Nathan PD
Expert Rev Anticancer Ther; 2015; 15(7):749-60. PubMed ID: 26107021
[TBL] [Abstract][Full Text] [Related]
25. Early experience with targeted therapy as a first-line adjuvant treatment for pediatric low-grade glioma.
Leclair NK; Lambert W; Roche K; Gillan E; Gell JJ; Lau CC; Wrubel G; Knopf J; Amin S; Anderson M; Martin JE; Bookland MJ; Hersh DS
Neurosurg Focus; 2022 Dec; 53(6):E15. PubMed ID: 36455272
[TBL] [Abstract][Full Text] [Related]
26. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
[TBL] [Abstract][Full Text] [Related]
27. Pneumocephalus in a Pediatric Patient with Glioma Receiving Trametinib.
Gorsi H; Marupudi NI; Sood S; Altinok D; Yankelevich M
Pediatr Neurosurg; 2020; 55(1):51-53. PubMed ID: 31661699
[TBL] [Abstract][Full Text] [Related]
28. Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors.
Lee RP; Foster KA; Lillard JC; Klimo P; Ellison DW; Orr B; Boop FA
J Neurosurg Pediatr; 2017 Sep; 20(3):247-255. PubMed ID: 28686121
[TBL] [Abstract][Full Text] [Related]
29. The distribution of BRAF gene fusions in solid tumors and response to targeted therapy.
Ross JS; Wang K; Chmielecki J; Gay L; Johnson A; Chudnovsky J; Yelensky R; Lipson D; Ali SM; Elvin JA; Vergilio JA; Roels S; Miller VA; Nakamura BN; Gray A; Wong MK; Stephens PJ
Int J Cancer; 2016 Feb; 138(4):881-90. PubMed ID: 26314551
[TBL] [Abstract][Full Text] [Related]
30. Use of Trametinib in Children and Young Adults With Progressive Low-grade Glioma and Glioneuronal Tumors.
Hanzlik E; Archambault B; El-Dairi M; Schroeder K; Patel MP; Lipp ES; Peters KB; Ashley DM; Landi D
J Pediatr Hematol Oncol; 2023 May; 45(4):e464-e470. PubMed ID: 36730221
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of disseminated pilocytic astrocytomas.
Gessi M; Engels AC; Lambert S; Rothämel T; von Hornstein S; Collins VP; Denkhaus D; Gnekow A; Pietsch T
Neuropathol Appl Neurobiol; 2016 Apr; 42(3):273-8. PubMed ID: 26084390
[TBL] [Abstract][Full Text] [Related]
32. Targeted MAPK Pathway Inhibitors in Patients With Disseminated Pilocytic Astrocytomas.
Drobysheva A; Klesse LJ; Bowers DC; Rajaram V; Rakheja D; Timmons CF; Wang J; Koral K; Gargan L; Ramos E; Park JY
J Natl Compr Canc Netw; 2017 Aug; 15(8):978-982. PubMed ID: 28784858
[TBL] [Abstract][Full Text] [Related]
33. Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report.
Burzynski SR; Weaver RA; Lewy RI; Janicki TJ; Jurida GF; Szymkowski BG; Khan MI; Bestak M
Drugs R D; 2004; 5(6):315-26. PubMed ID: 15563234
[TBL] [Abstract][Full Text] [Related]
34. Targeted Therapy Win in BRAF-Mutant Gliomas.
Cancer Discov; 2023 Nov; 13(11):2299-2300. PubMed ID: 37732735
[TBL] [Abstract][Full Text] [Related]
35. Tamoxifen and carboplatin for children with low-grade gliomas: a pilot study at St. Jude Children's Research Hospital.
Walter AW; Gajjar A; Reardon DA; Thompson SJ; Langston JW; Jones-Wallace D; Kun LE; Heideman RL
J Pediatr Hematol Oncol; 2000; 22(3):247-51. PubMed ID: 10864056
[TBL] [Abstract][Full Text] [Related]
36. Combined therapy with dabrafenib and trametinib in BRAF-mutated metastatic melanoma in a real-life setting: the INT Milan experience.
Cavalieri S; Di Guardo L; Cimminiello C; Bono A; Tolomio E; Colombetti A; Valeri B; Di Tolla G; de Braud F; Del Vecchio M
Tumori; 2016 Oct; 102(5):501-507. PubMed ID: 27470608
[TBL] [Abstract][Full Text] [Related]
37. Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.
Infante JR; Fecher LA; Falchook GS; Nallapareddy S; Gordon MS; Becerra C; DeMarini DJ; Cox DS; Xu Y; Morris SR; Peddareddigari VG; Le NT; Hart L; Bendell JC; Eckhardt G; Kurzrock R; Flaherty K; Burris HA; Messersmith WA
Lancet Oncol; 2012 Aug; 13(8):773-81. PubMed ID: 22805291
[TBL] [Abstract][Full Text] [Related]
38. Trametinib Toxicities in Patients With Low-grade Gliomas and Diabetes Insipidus: Related Findings?
Egan G; Hamilton J; McKeown T; Bouffet E; Tabori U; Dirks P; Bartels U
J Pediatr Hematol Oncol; 2020 May; 42(4):e248-e250. PubMed ID: 30676433
[TBL] [Abstract][Full Text] [Related]
39. Temozolomide in pediatric low-grade glioma.
Khaw SL; Coleman LT; Downie PA; Heath JA; Ashley DM
Pediatr Blood Cancer; 2007 Nov; 49(6):808-11. PubMed ID: 17588234
[TBL] [Abstract][Full Text] [Related]
40. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
